Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07478497

30 Day Insulin Balance Metabolic Health Optimization Protocol

Led by Efforia, Inc · Updated on 2026-03-17

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to explore how a dietary supplement called the Insulin Balance Formula may help support healthy insulin levels and its effects on weight, fatigue, and sugar cravings. The study focuses on generally healthy adults who want to maintain healthy insulin levels and improve overall metabolic health using this nutritional approach. It is an observational study where participants act as their own control in a single-arm design to detect initial signals of benefit and gather safety data. Participants will take the Insulin Balance Formula supplement daily for 30 days, starting with one capsule to assess tolerance and increasing to three capsules, ideally one before each meal or all at once. The formula contains five ingredients: Berberine, Beta Alanine, Zinc Citrate, Folate, and Fenugreek Extract. During the study, participants will follow a balanced diet and avoid introducing new supplements or health interventions. Throughout the 30-day period, participants will complete several assessments, including body composition measurement, the PROMIS Sleep Disturbance Scale, the Carbohydrate Craving Questionnaire, and evaluations of hunger and fatigue after meals. These will be done at baseline and study completion, with some hunger and fatigue assessments repeated randomly during the study. Participants are encouraged to provide honest feedback, and their privacy is protected. The study aims to generate meaningful data on how this supplement may support metabolic health and guide future research.

CONDITIONS

Brief Title

30 Day Insulin Balance Metabolic Health Optimization Protocol

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older who are generally healthy
  • Ability to read and understand English
  • Willingness and ability to provide informed consent and follow study procedures
Not Eligible

You will not qualify if you...

  • Known allergies
  • Pregnant or nursing individuals
  • Individuals with insulin disorders
  • Individuals with gastrointestinal disorders
  • Individuals with mental health conditions
  • Individuals with sleep disorders
  • Individuals currently on medication
  • Athletes under specific regulations
  • Individuals sensitive to fatigue

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 30 days

Participants take the Insulin Balance Supplement daily while following a balanced diet and complete assessments on body composition, sleep disturbance, carbohydrate cravings, and hunger & fatigue perception.

1 baseline visit and 1 visit at study completion with additional assessments repeated 6 times over 2 weeks

Trial Site Locations

Total: 1 location

1

Efforia

New York, New York, United States, 10003

Actively Recruiting

Loading map...

Research Team

M

Matthew Amsden

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

The Effects of Hass Avocados on Glycemic Control in Persons ...

Diabetes Mellitus, Type 2

Actively Recruiting

1 location

Evaluation of a Novel Insulin Sensitizer on Glycemic Control...

Type 1 Diabetes (T1D)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here